ArticleBMC infectious diseases2026
A catastrophic seven-year course of drug-resistant tuberculosis and lessons for multidisciplinary management: a case report.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWe describe the catastrophic seven-year journey of a young man with drug-resistant tuberculosis (TB) in China, initially managed with empiric therapy without baseline molecular testing. CASE PRESENTATION: He relapsed with rifampicin-resistant TB, complicated by empyema, bronchopleural fistula, and multiple failed surgeries. Management required prolonged, individualized therapy with severe toxicities, including linezolid-induced peripheral neuropathy, and staged thoracic reconstruction.
interpretationAlthough microbiological cure was achieved, the patient was left with severe post-tuberculosis lung disease and functional disability. This case highlights the consequences of omitting rapid molecular diagnostics, the essential role of multidisciplinary collaboration, and the need to extend TB care beyond microbiological cure to long-term rehabilitation. This case report is reported in accordance with the CARE guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.